515 Therapeutic advantage of chemotherapy drugs in combination with PARP inhibitor PF-01367338 (AG-014699) in human ovarian cancer cells
M. Ihnen, K. Manivong, M. Chalukya, J. Dering, T. Kolarova, G. Los, J. Christensen, R.S. Finn, D.S. Slamon, G.E. KonecnyVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)72222-9
File:
PDF, 99 KB
english, 2010